NeueHealth Q2 2022 Earnings Report
Key Takeaways
Bright Health Group reported a revenue of $1.6 billion, up 41.5% from Q2'21. The GAAP Net Loss was $251.3 million, and the Adjusted EBITDA Loss was $194.9 million. The Enterprise Medical Cost Ratio was 88.8%. The company reaffirmed its 2022 Consolidated Revenue, MCR, and Adjusted EBITDA guidance.
Revenue of $1.6 billion, up 41.5% from Q2'21.
GAAP Net Loss of $251.3 million.
Adjusted EBITDA Loss of $194.9 million.
Enterprise Medical Cost Ratio of 88.8%.
NeueHealth
NeueHealth
NeueHealth Revenue by Segment
Forward Guidance
Bright Health Group expects a total revenue of $6.8 billion to $7.1 billion with an expected enterprise Medical Cost Ratio between 90% and 94%. Bright HealthCare end-of-year membership is expected to be approximately 1,000,000, while NeueHealth Revenue is expected to be approximately $2.2 billion. Adjusted EBITDA for 2022 is expected to be a loss of between $500.0 million and $800.0 million
Revenue & Expenses
Visualization of income flow from segment revenue to net income